Click here to download article Pharmaceutical Executive: The Intelligence Diaries November 2008

Click here to download article Pharmaceutical Executive: Early Warnings May 2004

Practice Overview
Competition within today’s pharmaceutical industry is increasingly intense. Whether due to the increasing global economy, the blurring of traditional industry lines, rapid advances in science & technology, regulatory harmonization, e-commerce, continued mergers, acquisitions and alliances, or the growing expectations of customers, the acute challenge to maintain competitive advantage is affecting pharmaceutical companies of all sizes, in all lines of their businesses.

The future of the pharmaceutical industry depends on the ability of its major companies to discover, develop and market the best, most innovative, most effective and sought-after medicines and machines in the world. At the same time, the mid-size and smaller companies need to find their competitive niche in order to secure market share when operating within the same disease areas as the global giants formed by the mega mergers of recent years. To compete effectively in this fast-changing environment, market leaders recognize the need to monitor industry activity and competitor strategy as a regular part of doing business.

Fuld & Company’s Pharmaceuticals Practice understands all of this, providing all levels of competitive support from research to consulting, while maintaining the highest legal and ethical standards. We know the companies, the changing landscapes, and the competitive environment the future holds. We have been the intelligence professionals-of-choice for the pharmaceutical industry since 1990, when the first of our six specialty practices, Pharmaceutical Research, was founded. Since that time, over 100 biotech, pharmaceutical and diagnostics/device companies have come to Fuld & Company for their training, custom research, and systems consulting needs. On behalf of these numerous global clients, we regularly assess new product progress from early-stage development to product launch, technology partnerships between biotech and big pharma, and changing global technologies, regulations, and markets. We have researched over 60 different therapeutic categories or niches worldwide.

For further information on how you can improve your organization's strategic position and enhance operational effectiveness by implementing a competitive intelligence research program wherever you are in the world, please contact Cynthia Gerber Tomlinson, Vice President, Global Pharmaceuticals and Healthcare Practice (cgtomlinson@fuld.com or +1 617-492-5900) or Anthony Nagle, Managing Director of Fuld & Company Europe (tnagle@fuld.com or +44 (0) 20 7659 6999).

Project Experience

Rumor Verification - Using Public Agencies Can Help Confirm or Disprove Rumors

New Rivals - New Treatment Approaches Can Impact The Market For Traditional Treatments

Core Competencies - What is Your Strength, Really?

Analyzing A Competitor's Operations Can Lead To Significant Improvements In A Firm's Cost Structure

Knowing An Agency's Reaction to Innovative Products Is Critical

Determining Price and Cost Structures

Employee Retention - Can a Traditional Player Keep and Attract Star Talent?

The Changing Paradigm of the BioPharmaceutical Industry

The Use of IT - Generating More Uses for Existing Technology Platforms

Increasing Productivity By Branching Out

International Issues Demand International Resources

Merger Analysis - Study the Past to Predict the Future

E-Commerce - From OTC to DTC

Process Consulting

Distribution - How Do You Compete with Unique Distribution Strategies?

Product Positioning In A New Market Segment